Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,905 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort Study [Journal of Stroke and Cerebrovascular Diseases Volume 28, Issue 2, February 2019, Pages 267-275].
Zulfiqar M, Qeadan F, Ikram A, Farooqui M, Richardson SP, Calder CS, Quadri SA, Mathur P, Ford C, Ortega-Gutierrez S, Leira E, Snow H, Gonzalez JN, Zafar A. Zulfiqar M, et al. Among authors: ford c. J Stroke Cerebrovasc Dis. 2019 Apr;28(4):1149. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.022. Epub 2019 Feb 8. J Stroke Cerebrovasc Dis. 2019. PMID: 30745231 No abstract available.
Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort Study.
Zulfiqar M, Qeadan F, Ikram A, Farooqui M, Richardson SP, Calder CS, Quadri SA, Mathur P, Ford C, O Gutierrez S, Liera E, Snow H, N Gonzalez J, Zafar A. Zulfiqar M, et al. Among authors: ford c. J Stroke Cerebrovasc Dis. 2019 Feb;28(2):267-275. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.050. Epub 2018 Oct 29. J Stroke Cerebrovasc Dis. 2019. PMID: 30385221
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinsky J. Ford C, et al. Mult Scler. 2010 Mar;16(3):342-50. doi: 10.1177/1352458509358088. Epub 2010 Jan 27. Mult Scler. 2010. PMID: 20106943 Free PMC article. Clinical Trial.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Multivoxel 1H-MRS of stroke.
Ford CC, Griffey RH, Matwiyoff NA, Rosenberg GA. Ford CC, et al. Neurology. 1992 Jul;42(7):1408-12. doi: 10.1212/wnl.42.7.1408. Neurology. 1992. PMID: 1320220
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Voskuhl RR, Wang H, Wu TC, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardens J, Bernard JT, Corboy JR, Cross AH, Dhib-Jalbut S, Ford CC, Frohman EM, Giesser B, Jacobs D, Kasper LH, Lynch S, Parry G, Racke MK, Reder AT, Rose J, Wingerchuk DM, MacKenzie-Graham AJ, Arnold DL, Tseng CH, Elashoff R. Voskuhl RR, et al. Among authors: ford cc. Lancet Neurol. 2016 Jan;15(1):35-46. doi: 10.1016/S1474-4422(15)00322-1. Epub 2015 Nov 29. Lancet Neurol. 2016. PMID: 26621682 Clinical Trial.
1,905 results